Nasal intermittent positive pressure ventilation (NIPPV) during neonatal
endotracheal intubation: A randomized controlled trial
Abstract
Background: The present study aimed to determine whether the
use of nasal intermittent positive pressure ventilation (NIPPV) during
neonatal endotracheal intubation increases the rate of successful
intubation without physiological instability during all intubation
attempts. Material and Methods: The present study was designed
as a prospective, multicenter, randomized, controlled study conducted
with neonates undergoing endotracheal intubation. The infants were
assigned randomly to either the NIPPV group or the standard care group.
The primary outcome was successful intubation without physiological
instability (defined as ≥20% decline in the peripheral oxygen
saturation [SpO 2] from pre-intubation value or
bradycardia with a heart rate of <100 beats per minute) during
all intubation attempts. Results: A total of 150 infants were
enrolled (75 for the NIPPV group and 75 for the standart-care group).
The infants had a mean postmenstrual age of 32.5 weeks and a median
weight of 1552 g at the time of intubation. The incidence of successful
intubation without physiological instability during all intubation
attempts was significantly higher in the NIPPV group (64%) compared to
the standard-care group (42.7%) (p = 0.009). This difference was
particularly significant when inexperienced practitioners were involved.
In the NIPPV group, the rate of bradycardia and severe desaturation was
significantly lower, while the lowest SpO 2 level and
the lowest heart rate level were significanlty higher.
Conclusion: NIPPV during endotracheal intubation increases the
incidence of successful intubation without physiological instability
during all intubation attempts in neonates, while reducing the rate of
hypoxia and bradycardia.